- Home
- Advocacy
- Latest News and Practice Data
- Hospital Survey Seeks to Understand Testing on Patients Suspected of Having Viral Hemorrhagic Fever
A brief survey from the Centers for Disease Control and Prevention (CDC) , the CAP, the Association for Molecular Pathology (AMP), Association of Public Health Laboratories (APHL), American Society for Microbiology (ASM), COLA is being distributed to better understand the existing policies and practices in U.S. hospitals related to performing routine clinical laboratory testing on patients suspected of having a viral hemorrhagic fever (VHF). This survey is being distributed through the CAP’s partnership with the CDC, and will inform future policy and educational resources on this issue for U.S. hospitals and the clinical laboratory community.
If you work in a hospital system, please forward this link to anyone who may be able to provide valuable insight on this topic. It should take less than 10 minutes to complete. The deadline for responses is March 20, 2024.